Microbial Nand O-demethylation of a thebaine derivative

Details for Australian Patent Application No. 2011203283 (hide)

Owner Reckitt Benckiser Healthcare (UK) Limited

Inventors Davis, John Alfred; Carnell, Andrew John

Agent Madderns

Pub. Number AU-A-2011203283

Parent 2009251172

Filing date 4 July 2011

Wipo publication date 28 July 2011

International Classifications

C07D 489/12 (2006.01) Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:

C12P 17/18 (2006.01) Preparation of heterocyclic carbon compounds with only O, N, S, Se, or Te as ring hetero atoms - containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin

Event Publications

21 July 2011 Complete Application Filed

28 July 2011 Application Open to Public Inspection

  Published as AU-A-2011203283

27 September 2012 Assignment before Grant

  Reckitt Benckiser Healthcare (UK) Limited The application has been assigned to RB Pharmaceuticals Limited

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011203284-Protein Formulation

2011203282-A method of making bamboo-surfaced layered Venetian blind slats